Literature DB >> 3176087

Effect of aminophylline on postischemic edema and brain damage in cats.

M Seida1, H G Wagner, K Vass, I Klatzo.   

Abstract

We attempted to ameliorate postischemic edema and brain tissue injury in cats by administering aminophylline to reduce the reactive hyperemia that supposedly aggravates both these sequelae. Forty-one cats were subjected to 1 hour of middle cerebral artery occlusion and were killed after 3 hours, 3 days, or 14 days of recirculation; one half of the cats received 0.916 ml/kg of a 25 mg/ml solution of aminophylline by infusion at a constant rate via the femoral vein starting 10 minutes before release of the occlusion and continuing for 5 minutes after initiation of recirculation; the other half received saline. Regional cerebral blood flow was monitored by the hydrogen clearance method and water content was evaluated by specific gravity measurements after 3 hours of recirculation; the status of the blood-brain barrier was assessed with Evans blue tracer. Morphologic observations were carried out in cats killed after 3 or 14 days of recirculation. Aminophylline-treated cats killed after 3 hours of recirculation showed significantly reduced hyperemia and edema and no leakage of Evans blue, which was present in all untreated cats killed after 3 hours or 3 days of recirculation. Morphologic observations revealed conspicuously more severe ischemic brain tissue damage in the untreated than in the aminophylline-treated cats after 3 and 14 days of recirculation. Our studies indicate the beneficial effect of administration of aminophylline in the amelioration of postischemic edema and brain tissue injury, which is presumably achieved by reduction of reactive hyperemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3176087     DOI: 10.1161/01.str.19.10.1275

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  4 in total

1.  Effect of dilazep dihydrochloride against ischemia and reperfusion-induced disruption of blood-brain barrier in rats: a quantitative study.

Authors:  J Kawagoe; K Abe; J Ikuta; N Igarashi; S Shimizu; Y Yamauchi; K Kogure
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

2.  Theophylline as an add-on to thrombolytic therapy in acute ischaemic stroke (TEA-Stroke): A randomized, double-blinded, placebo-controlled, two-centre phase II study.

Authors:  Boris Modrau; Niels Hjort; Leif Østergaard; Kim Mouridsen; Grethe Andersen; Flemming Winther Bach
Journal:  Eur Stroke J       Date:  2016-10-14

3.  Machine Learning-Based Prediction of Brain Tissue Infarction in Patients With Acute Ischemic Stroke Treated With Theophylline as an Add-On to Thrombolytic Therapy: A Randomized Clinical Trial Subgroup Analysis.

Authors:  Boris Modrau; Anthony Winder; Niels Hjort; Martin Nygård Johansen; Grethe Andersen; Jens Fiehler; Henrik Vorum; Nils D Forkert
Journal:  Front Neurol       Date:  2021-05-21       Impact factor: 4.003

4.  Perfusion Changes in Acute Stroke Treated with Theophylline as an Add-on to Thrombolysis : A Randomized Clinical Trial Subgroup Analysis.

Authors:  Boris Modrau; Anthony Winder; Niels Hjort; Martin Nygård Johansen; Grethe Andersen; Jens Fiehler; Henrik Vorum; Nils D Forkert
Journal:  Clin Neuroradiol       Date:  2021-07-14       Impact factor: 3.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.